Topical steroid addiction in atopic dermatitis

被引：28

作者：

Fukaya, Mototsugu ^{[1
]}

Sato, Kenji ^{[2
]}

Sato, Mitsuko ^{[3
]}

Kimata, Hajime ^{[4
]}

Fujisawa, Shigeki ^{[5
]}

Dozono, Haruhiko ^{[6
]}

Yoshizawa, Jun ^{[7
]}

Minaguchi, Satoko ^{[8
]}

机构：

[1] Tsurumai Kouen Clin, Nagoya, Aichi, Japan

[2] Hannan Chuo Hosp, Dept Dermatol, Osaka, Japan

[3] Sato Pediat Clin, Osaka, Japan

[4] Kimata Hajime Clin, Osaka, Japan

[5] Fujisawa Dermatol Clin, Tokyo, Japan

[6] Dozono Med House, Kagoshima, Japan

[7] Yoshizawa Dermatol Clin, Yokohama, Kanagawa, Japan

[8] Kounosu Kyousei Hosp, Dept Dermatol, Saitama, Japan

来源：

DRUG HEALTHCARE AND PATIENT SAFETY | 2014年 / 6卷

关键词：

topical steroid addiction; atopic dermatitis; red burning skin syndrome; rebound; corticosteroid; eczema;

D O I：

10.2147/DHPS.S6920

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The American Academy of Dermatology published a new guideline regarding topical therapy in atopic dermatitis in May 2014. Although topical steroid addiction or red burning skin syndrome had been mentioned as possible side effects of topical steroids in a 2006 review article in the Journal of the American Academy of Dermatology, no statement was made regarding this illness in the new guidelines. This suggests that there are still controversies regarding this illness. Here, we describe the clinical features of topical steroid addiction or red burning skin syndrome, based on the treatment of many cases of the illness. Because there have been few articles in the medical literature regarding this illness, the description in this article will be of some benefit to better understand the illness and to spur discussion regarding topical steroid addiction or red burning skin syndrome.

引用

页码：131 / 138

页数：8

共 17 条

[1] Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study [J].